Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-13

Clinical Trial Update: Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris [NA]

View source ↗

Summary

This clinical trial update reports on the efficacy and tolerability of DispersinB Acne Cleanser for mild-to-moderate acne vulgaris. The study is sponsored by Ka…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DispersinB Acne Cleanser (Dispersin B)

Snippet

Sponsor: Kane Biotech Inc | Conditions: Acne Vulgaris on the Face | NA | Status: NOT_YET_RECRUITING